Avoro Capital Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Avoro Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $117 Million - $213 Million	1,875,000 Added 36.59%	7,000,000 $797 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $7.37 Million - $10.6 Million	125,000 Added 2.5%	5,125,000 $317 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $119 Million - $175 Million	-1,500,000 Reduced 23.08%	5,000,000 $399 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $242 Million - $307 Million	-2,795,000 Reduced 30.07%	6,500,000 $684 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $29.1 Million - $35.4 Million	295,000 Added 3.28%	9,295,000 $1 Billion
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $90.5 Million - $114 Million	1,350,000 Added 17.65%	9,000,000 $658 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $91.1 Million - $132 Million	1,650,000 Added 27.5%	7,650,000 $594 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $43 Million - $81.2 Million	1,425,000 Added 31.15%	6,000,000 $333 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $14.3 Million - $22.2 Million	575,000 Added 14.37%	4,575,000 $136 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $91.2 Million - $114 Million	4,000,000 New	4,000,000 $96.2 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.